Becker's Healthcare March 5, 2024
Mariah Taylor

The FDA approved a new drug for first-line lung cancer treatment.

Amivantamab-vmjw was approved with carboplatin and pemetrexed for locally advanced or metastatic non-small cell lung cancer with epidermal growth...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
FDA Approves Third Tocilizumab Biosimilar
The Biden Administration’s Swan Song on Digital Health: Two FDA Guidances on Artificial Intelligence and FDA’s Defense of its Clinical Decision Support Guidance
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown

Share This Article